Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

Fouad A, Sabry D, Ahmed R, Kamal M, Allah SA, Marzouk S, Amin M, Abd El Aziz R, El Badri A, Khattab H, Helmy D.

Int J Gen Med. 2013 Mar 12;6:127-34. doi: 10.2147/IJGM.S36433. Print 2013.

2.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841
3.
4.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
5.

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

Esmat G, El Akel W, Metwally M, Soliman A, Doss W, Hamid MA, Kamal M, Zalata K, Khattab H, El-Kassas M, Esmat M, Hasan A, El-Raziky M.

Indian J Gastroenterol. 2009 Mar-Apr;28(2):45-8. doi: 10.1007/s12664-009-0016-1. Epub 2009 Aug 21.

PMID:
19696987
6.

Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.

Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A.

Gastroenterology. 2006 May;130(6):1661-9. Epub 2006 Mar 6.

PMID:
16697730
7.

Hepatic steatosis in Iranian patients with chronic hepatitis C.

Minakari M, Sameni FK, Shalmani HM, Molaee M, Zali MR.

Med Princ Pract. 2008;17(2):126-30. doi: 10.1159/000112966. Epub 2008 Feb 19.

PMID:
18287796
8.

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.

Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ.

J Viral Hepat. 2011 Apr;18(4):e144-52. doi: 10.1111/j.1365-2893.2010.01394.x. Epub 2010 Nov 10.

PMID:
21070504
9.

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Samejima Y, Goto H.

Liver Int. 2010 Apr;30(4):554-9. doi: 10.1111/j.1478-3231.2009.02164.x. Epub 2009 Nov 27.

PMID:
19951380
10.

Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.

Dolmazashvili E, Zhamutashvili M, Svanidze M, Nizharadze N, Abutidze A.

Georgian Med News. 2008 Dec;(165):83-7.

PMID:
19124923
11.

Hepatitis C virus infection and liver steatosis.

Ramalho F.

Antiviral Res. 2003 Oct;60(2):125-7. Review.

PMID:
14638408
12.

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.

Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS.

Antivir Ther. 2005;10(3):405-15.

PMID:
15918331
13.

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

Giannini E, Ceppa P, Botta F, Mastracci L, Romagnoli P, Comino I, Pasini A, Risso D, Lantieri PB, Icardi G, Barreca T, Testa R.

Am J Gastroenterol. 2000 Nov;95(11):3211-7.

PMID:
11095344
14.

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis.

Fujie H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, Makuuchi M, Matsuura Y, Miyamura T, Kimura S, Koike K.

J Med Virol. 1999 Oct;59(2):141-5.

PMID:
10459147
15.

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallée M, Heaton S, Conrad A, Pockros PJ, McHutchison JG.

J Hepatol. 2004 Mar;40(3):484-90.

PMID:
15123364
16.

Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.

Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):57-60.

PMID:
16929588
17.

Lipid profile and hepatic steatosis in hepatitis C infected egyptian survivors of childhood cancer.

Al-Tawil MM, Shoeeb AS, Abbas A, El-Tawil A, El-Sayed MH.

Pediatr Hematol Oncol. 2015 Feb;32(1):70-7. doi: 10.3109/08880018.2013.825355. Epub 2013 Sep 19.

PMID:
24050726
18.

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN.

Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.

PMID:
18190648
19.

Steatosis in hepatitis C virus infection. Response to anti-viral therapy.

Szanto P, Grigorescu M, Dumitru I, Serban A.

J Gastrointestin Liver Dis. 2006 Jun;15(2):117-24.

20.

Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

Adinolfi LE, Utili R, Andreana A, Tripodi MF, Marracino M, Gambardella M, Giordano M, Ruggiero G.

Dig Dis Sci. 2001 Aug;46(8):1677-83.

PMID:
11508667
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk